The findings (13) suggested that patients with PD and MSA may have higher levels of pS129-α-syn in oEVs in comparison to HCs, while patients with MSA may have lower tau levels in nEVs and oEVs in comparison to patients with PD and HCs. This evidence concerns the gene MAPT and multiple system atrophy.